SCHEMBL2374388

SCHEMBL2374388

CC1Cc2ccc(-c3ccnn3C)cc2CCN1C(=O)C(F)(F)F

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PDK1 Q15118 2/20 0.46
PDK2 Q15119 2/20 0.46
PDK3 Q15120 2/20 0.46
PDK4 Q16654 2/20 0.46
USP30 Q70CQ3 1/20 0.42
SCD5 Q86SK9 1/20 0.40
DRD2 P14416 2/20 0.39
DRD3 P35462 1/20 0.39
GSK3B P49841 1/20 0.38
DYRK1A Q13627 1/20 0.38
ABL1 P00519 1/20 0.37
CYP11B2 P19099 1/20 0.37
IDH1 O75874 1/20 0.37
ESR1 P03372 5/20 0.36
ESR2 Q92731 5/20 0.36
P2RX7 Q99572 3/20 0.36
PRMT5 O14744 1/20 0.36
WDR77 Q9BQA1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2365640 0.81 HTR2A (0.41) ESR1ESR2
SCHEMBL1903827 0.78 ESR2 (0.58) DRD2DRD3ESR1ESR2
SCHEMBL2365617 0.76 PDK1 (0.45) PDK1PDK2PDK3PDK4USP30
SCHEMBL1095486 0.76 USP30 (0.44) PDK1PDK2PDK3PDK4USP30
SCHEMBL1904807 0.75 ESR1 (0.50) DRD2ESR1ESR2
SCHEMBL31164758 0.71 ESR2 (0.61) PDK1PDK2PDK3PDK4USP30
SCHEMBL6631121 0.69 ESR1 (0.41) ESR1ESR2
SCHEMBL26583761 0.69 PDK1 (0.70) PDK1PDK2PDK3PDK4USP30
SCHEMBL31164675 0.65 ASIC3 (0.55) PDK1PDK2PDK3PDK4DRD2
SCHEMBL4227747 0.65 ESR1 (0.40) ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2363394-A1 8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its salts, solvates or hydrates and its use for the treatment of CNS disorders Arena Pharmaceuticals, Inc. (US) 2011-09-07 EP disclosed
EP-1411881-A4 5HT sb 2C /sb RECEPTOR MODULATORS ARENA PHARM INC (US) 2004-07-07 EP disclosed
EP-1411881-A2 5HT sb 2C /sb RECEPTOR MODULATORS Arena Pharmaceuticals, Inc. (US) 2004-04-28 EP disclosed
WO-2003086306-A2 5HT2C RECEPTOR MODULATORS ARENA PHARMACEUTICALS, INC. (US) 2003-10-23 WO disclosed